Plasma fatty acid changes following consumption of dietary oils containing n-3, n-6, and n-9 fatty acids at different proportions: Preliminary findings of the Canola Oil Multicenter Intervention Trial (COMIT)

Trials

Volumn 15, Issue 1, 2014, Pages

  Senanayake, Vijitha K ^a,e   Pu, Shuaihua ^a   Jenkins, David A ^b   Lamarche, Benoît ^c   Kris Etherton, Penny M ^d   West, Sheila G ^d   Fleming, Jennifer A ^d   Liu, Xiaoran ^d   McCrea, Cindy E ^d   Jones, Peter J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e Phenomenome Discoveries Inc   (Canada)

Author keywords

Canola oil; Cardiovascular diseases; DHA; Lipoproteins; Metabolic syndrome; Plasma fatty acids; Randomized controlled clinical trial; Serum lipids

Indexed keywords

ACYL COENZYME A DESATURASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CANOLA OIL; CHOLESTEROL; CORN OIL; DOCOSAHEXAENOIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OMEGA 9 FATTY ACID; SAFFLOWER OIL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LONG CHAIN FATTY ACID; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; LINSEED OIL; LIPID; MONOUNSATURATED FATTY ACID; OLEIC ACID;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY FAT; BODY WEIGHT; CANADA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIETARY COMPLIANCE; DOUBLE BLIND PROCEDURE; FAT INTAKE; FAT MASS; FATTY ACID BLOOD LEVEL; FEMALE; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HUMAN; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; UNITED STATES; WAIST CIRCUMFERENCE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; DIET; DIET THERAPY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; OBESITY, ABDOMINAL; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT DROPOUTS; TIME; TREATMENT OUTCOME;

ADULT; BIOMARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CANADA; CARDIOVASCULAR DISEASES; CORN OIL; CROSS-OVER STUDIES; DIET; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; LINSEED OIL; LIPIDS; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; OLEIC ACID; PATIENT COMPLIANCE; PATIENT DROPOUTS; PENNSYLVANIA; SAFFLOWER OIL; TIME FACTORS; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 84900344483     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-136     Document Type: Article

References (52)

1. Slattery ML, Randall DE. Trends in coronary heart disease mortality and food consumption in the United States between 1909 and 1980. Am J Clin Nutr 1988, 47:1060-1067.
2. McGuire S. U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, January 2011. Adv Nutr 2011, 2:293-294. 10.3945/an.111.000430, 3090168, 22332062.
3. Rasmussen BM, Vessby B, Uusitupa M, Berglund L, Pedersen E, Riccardi G, Rivellese AA, Tapsell L, Hermansen K. Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy subjects. Am J Clin Nutr 2006, 83:221-226.
4. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992, 12:911-919. 10.1161/01.ATV.12.8.911, 1386252.
5. Rivellese AA, Maffettone A, Vessby B, Uusitupa M, Hermansen K, Berglund L, Louheranta A, Meyer BJ, Riccardi G. Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects. Atherosclerosis 2003, 167:149-158. 10.1016/S0021-9150(02)00424-0, 12618280.
6. Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L, Berglund J, Pulkki K, Basu S, Uusitupa M, Rudling M, Arner P, Cederholm T, Ahlström H, Risérus U. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr 2012, 95:1003-1012. 10.3945/ajcn.111.030114, 22492369.
7. Hodson L, Skeaff CM, Chisholm WA. The effect of replacing dietary saturated fat with polyunsaturated or monounsaturated fat on plasma lipids in free-living young adults. Eur J Clin Nutr 2001, 55:908-915. 10.1038/sj.ejcn.1601234, 11593354.
8. Hunter JE, Zhang J, Kris-Etherton PM. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 2010, 91:46-63. 10.3945/ajcn.2009.27661, 19939984.
9. Buhr KA. Surrogate end points in secondary analyses of cardiovascular trials. Prog Cardiovasc Dis 2012, 54:343-350. 10.1016/j.pcad.2011.09.007, 22226002.
10. Baylin A, Ruiz-Narvaez E, Kraft P, Campos H. Alpha-Linolenic acid, Delta6-desaturase gene polymorphism, and the risk of nonfatal myocardial infarction. Am J Clin Nutr 2007, 85:554-560.
11. Hussein N, Ah-Sing E, Wilkinson P, Leach C, Griffin BA, Millward DJ. Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J Lipid Res 2005, 46:269-280.
12. Egert S, Somoza V, Kannenberg F, Fobker M, Krome K, Erbersdobler HF, Wahrburg U. Influence of three rapeseed oil-rich diets, fortified with alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on the composition and oxidizability of low-density lipoproteins: results of a controlled study in healthy volunteers. Eur J Clin Nutr 2007, 61:314-325. 10.1038/sj.ejcn.1602523, 16969378.
13. Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr 2010, 104:1586-1600. 10.1017/S0007114510004010, 21118617.
14. Yashodhara BM, Umakanth S, Pappachan JM, Bhat SK, Kamath R, Choo BH. Omega-3 fatty acids: a comprehensive review of their role in health and disease. Postgrad Med J 2009, 85:84-90. 10.1136/pgmj.2008.073338, 19329703.
15. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003, 108:155-160. 10.1161/01.CIR.0000079224.46084.C2, 12821543.
16. Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, Ringel A, Davis JM, Hibbeln JR. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013, 346:e8707. 10.1136/bmj.e8707, 23386268.
17. Stenvinkel P. Endothelial dysfunction and inflammation-is there a link?. Nephrol Dial Transplant 2001, 16:1968-1971. 10.1093/ndt/16.10.1968, 11572879.
18. van Bussel BC, Soedamah-Muthu SS, Henry RM, Schalkwijk CG, Ferreira I, Chaturvedi N, Toeller M, Fuller JH, Stehouwer CD. Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: The EURODIAB study. Nutr Metab Cardiovasc Dis 2013, 23:758-64. 10.1016/j.numecd.2012.04.005, 22795869.
19. Duvnjak L, Duvnjak M. The metabolic syndrome - an ongoing story. J Physiol Pharmacol 2009, 60(Suppl 7):19-24.
20. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645. 10.1161/CIRCULATIONAHA.109.192644, 19805654.
21. Potenza MV, Mechanick JI. The metabolic syndrome: definition, global impact, and pathophysiology. Nutr Clin Pract 2009, 24:560-577. 10.1177/0884533609342436, 19841245.
22. Muoio DM, Newgard CB. Obesity-related derangements in metabolic regulation. Annu Rev Biochem 2006, 75:367-401. 10.1146/annurev.biochem.75.103004.142512, 16756496.
23. Gillingham LG, Robinson KS, Jones PJ. Effect of high-oleic canola and flaxseed oils on energy expenditure and body composition in hypercholesterolemic subjects. Metabolism 2012, 61:1598-1605. 10.1016/j.metabol.2012.04.016, 22698766.
24. Due A, Larsen TM, Hermansen K, Stender S, Holst JJ, Toubro S, Martinussen T, Astrup A. Comparison of the effects on insulin resistance and glucose tolerance of 6-mo high-monounsaturated-fat, low-fat, and control diets. Am J Clin Nutr 2008, 87:855-862.
25. Buckley JD, Howe PR. Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes Rev 2009, 10:648-659. 10.1111/j.1467-789X.2009.00584.x, 19460115.
26. Martinez-Victoria E, Yago MD. Omega 3 polyunsaturated fatty acids and body weight. Br J Nutr 2012, 107(Suppl 2):S107-116.
27. Merino J, Megias-Rangil I, Ferre R, Plana N, Girona J, Rabasa A, Aragones G, Cabre A, Bonada A, Heras M, Masana L. Body weight loss by very-low-calorie diet program improves small artery reactive hyperemia in severely obese patients. Obes Surg 2013, 23:17-23. 10.1007/s11695-012-0729-6, 22918551.
28. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438. 10.1161/01.CIR.0000111245.75752.C6, 14744958.
29. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480. 10.1111/j.1464-5491.2006.01858.x, 16681555.
30. Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 1990, 51:241-247.
31. Gillingham LG, Gustafson JA, Han SY, Jassal DS, Jones PJ. High-oleic rapeseed (canola) and flaxseed oils modulate serum lipids and inflammatory biomarkers in hypercholesterolaemic subjects. Br J Nutr 2011, 105:417-427. 10.1017/S0007114510003697, 20875216.
32. McCrea CE, Skulas-Ray AC, Chow M, West SG. Test-retest reliability of pulse amplitude tonometry measures of vascular endothelial function: implications for clinical trial design. Vasc Med 2012, 17:29-36. 10.1177/1358863X11433188, 3513268, 22363016.
33. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
34. Cortes B, Nunez I, Cofan M, Gilabert R, Perez-Heras A, Casals E, Deulofeu R, Ros E. Acute effects of high-fat meals enriched with walnuts or olive oil on postprandial endothelial function. J Am Coll Cardiol 2006, 48:1666-1671.
35. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Sheffy J, Schnall RP, Karas RH, Udelson JE. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003, 146:168-174. 10.1016/S0002-8703(03)00094-2, 12851627.
36. Liu J, Wang J, Jin Y, Roethig HJ, Unverdorben M. Variability of peripheral arterial tonometry in the measurement of endothelial function in healthy men. Clin Cardiol 2009, 32:700-704. 10.1002/clc.20668, 20027662.
37. Kaur G, Begg DP, Barr D, Garg M, Cameron-Smith D, Sinclair AJ. Short-term docosapentaenoic acid (22:5 n-3) supplementation increases tissue docosapentaenoic acid, DHA and EPA concentrations in rats. Br J Nutr 2010, 103:32-37. 10.1017/S0007114509991334, 19650956.
38. Mozaffarian D, Wu JH. (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?. J Nutr 2012, 142:614S-625S. 10.3945/jn.111.149633, 3278271, 22279134.
39. Sagara M, Njelekela M, Teramoto T, Taguchi T, Mori M, Armitage L, Birt N, Birt C, Yamori Y. Effects of docosahexaenoic Acid supplementation on blood pressure, heart rate, and serum lipids in Scottish men with hypertension and hypercholesterolemia. Int J Hypertens 2011, 2011:809198. 3057036, 21423683.
40. Theobald HE, Chowienczyk PJ, Whittall R, Humphries SE, Sanders TA. LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women. Am J Clin Nutr 2004, 79:558-563.
41. Davidson MH, Maki KC, Kalkowski J, Schaefer EJ, Torri SA, Drennan KB. Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial. J Am Coll Nutr 1997, 16:236-243. 10.1080/07315724.1997.10718680, 9176830.
42. Nallamothu BK, Hayward RA, Bates ER. Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation 2008, 118:1294-1303. 10.1161/CIRCULATIONAHA.107.703579, 18794402.
43. Kwak JH, Paik JK, Kim HI, Kim OY, Shin DY, Kim HJ, Lee JH, Lee JH. Dietary treatment with rice containing resistant starch improves markers of endothelial function with reduction of postprandial blood glucose and oxidative stress in patients with prediabetes or newly diagnosed type 2 diabetes. Atherosclerosis 2012, 224:457-464. 10.1016/j.atherosclerosis.2012.08.003, 22954674.
44. Ros E, Nunez I, Perez-Heras A, Serra M, Gilabert R, Casals E, Deulofeu R. A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 2004, 109:1609-1614. 10.1161/01.CIR.0000124477.91474.FF, 15037535.
45. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007, 115:1285-1295.
46. Hamburg NM, Benjamin EJ. Assessment of endothelial function using digital pulse amplitude tonometry. Trends Cardiovasc Med 2009, 19:6-11. 10.1016/j.tcm.2009.03.001, 3777618, 19467447.
47. Gokce N, Keaney JF, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Vita JA. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003, 41:1769-1775. 10.1016/S0735-1097(03)00333-4, 12767663.
48. Truswell AS, Choudhury N. Monounsaturated oils do not all have the same effect on plasma cholesterol. Eur J Clin Nutr 1998, 52:312-315. 10.1038/sj.ejcn.1600566, 9630379.
49. Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 2010, 21:781-792. 10.1016/j.jnutbio.2009.12.004, 20382009.
50. Onkelinx S, Cornelissen V, Goetschalckx K, Thomaes T, Verhamme P, Vanhees L. Reproducibility of different methods to measure the endothelial function. Vasc Med 2012, 17:79-84. 10.1177/1358863X12436708, 22402933.
51. Williams MR, Westerman RA, Kingwell BA, Paige J, Blombery PA, Sudhir K, Komesaroff PA. Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab 2001, 86:5389-5395. 10.1210/jcem.86.11.8013, 11701712.
52. Njike VY, Faridi Z, Shuval K, Dutta S, Kay CD, West SG, Kris-Etherton PM, Katz DL. Effects of sugar-sweetened and sugar-free cocoa on endothelial function in overweight adults. Int J Cardiol 2009, 149:83-88.